Skip to Main Content

MiMedx Group, Inc. Securities Fraud Class Action

View Complaint
COMPANY         MiMedx Group Inc.
COURT United States District Court for the Northern District of Georgia 
CASE NUMBER 18-cv-00830
JUDGE The Honorable William McCrary Ray II
CLASS PERIOD  March 7, 2013 - June 29, 2018
SECURITY TYPE  Common Stock

Case Background:

On February 23, 2018, the initial complaint in this securities class action was filed against MiMedx Group Inc. (“MiMedx” or the “Company”), and certain of MiMedx’s directors and officers, asserting violations of Sections 10(b) and 20(a) of the Securities Exchange Act. This is a federal securities class action lawsuit brought on behalf of all persons or entities that purchased or otherwise acquired the publicly traded common stock of MiMedx between March 7, 2013 and June 29, 2018, both dates inclusive (the “Class Period”). 

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) MiMedx was engaged in a "channel-stuffing" scheme designed to inappropriately recognize revenue that had not yet been realized; (2) the Company lacked adequate internal controls over financial reporting; and (3) as a result of the foregoing, MiMedx's publicly disseminated financial statements were materially false and misleading.

Current Status of Case:

On March 30, 2020, Lead Plaintiffs filed a second amended complaint (the “Amended Complaint”).  Defendants filed a Motion to Dismiss the Amended Complaint on May 29, 2020. On March 25, 2021, the Court granted Defendants’ Motion to Dismiss.  On February 25, 2022, Lead Plaintiffs filed a Notice of Appeal to the United States Court of Appeals for the Eleventh Circuit.  On July 10, 2023, the Eight Circuit Court of Appeals affirmed in part and vacated in part the Order dismissing the case.  This action had been sent back to the District Court for further proceedings and is ongoing.  

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.

Please complete this form and list your purchase and sale transaction(s) MiMedx Group, Inc. (“MiMedx”) (Nasdaq: MDXG) securities between March 7, 2013 and February 21, 2018, both dates inclusive (the “Class Period”).

You may also contact Jon Naji, Esq. at (484) 270-1453; or you may submit your information via email at info@ktmc.com, or you may click here to print a PDF of this form.

SUBMIT YOUR INFORMATION
* Denotes required field
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of MiMedx Group, Inc. (2018) prior to the Class Period?
Are you a current or former employee of MiMedx Group, Inc. (2018)?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email